Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain

Summary

The primary objective of the study is to evaluate the safety and efficacy of bicifadine 400 mg BID for up to one year in patients with moderate to severe chronic low back pain. The secondary objectives are to compare the long-term safety of bicifadine to standard of care therapy, to evaluate the safety of bicifadine following discontinuation of dosing, and to evaluate the safety and efficacy of lower doses of bicifadine in patients who do not tolerate bicifadine 400 mg BID.

Timeline

Start

2004-12

Primary completion

—

Completion

—

Drugs

Indications